loader2
Partner With Us NRI

Divis Laboratories Ltd share Price Today

Company details

4,551.70
4,598.95
3,295.30
4,670.00
6M Return 17.12%
1Y Return 25.57%
Mkt Cap.(Cr) 121,340.57
Volume 266,585
Div Yield 0.66%
OI
-
OI Chg %
-
Volume 266,585
NSE

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals company Divi's Laboratories announced Q3FY24 & 9MFY24 results:

Consolidated Q3FY24:

  • Total Income: Rs 1,950 crore, compared to Rs 1,821 crore in the corresponding quarter of the previous year.
  • Material Consumption: Approximately 39% of sales revenue.
  • Profit Before Tax (PBT): Rs 489 crore, compared to Rs 435 crore in the corresponding quarter of the previous year.
  • Profit After Tax (PAT): Rs 358 crore, compared to Rs 306 crore in the corresponding quarter of the previous year.

Standalone Q3FY24:

  • Total Income: Recorded at Rs 1,902 crore in Q3FY24 compared to Rs 1,807 crore in Q3FY23.
  • Profit Before Tax (PBT): Stood at Rs 490 crore in Q3FY24, up from Rs 439 crore in Q3FY23.
  • Profit After Tax (PAT): Amounted to Rs 358 crore in Q3FY24, higher than the Rs 310 crore in Q3FY23.
  • Forex Gain: Registered at Rs 17 crore in Q3FY24, decreased from Rs 49 crore in Q3FY23.

Consolidated 9MFY24:

  • Total Income: Rs 5,804 crore, compared to Rs 6,099 crore in the corresponding previous period.
  • Profit After Tax (PAT): Rs 1,062 crore, compared to Rs 1,502 crore in the corresponding previous period.
  • Forex Gain: Rs 32 crore, compared to Rs 134 crore in the previous 9-month period.

Standalone 9MFY24:

  • Total Income: For 9MFY24, it amounted to Rs 5,665 crore, down from Rs 6,003 crore in 9MFY23.
  • Profit Before Tax (PBT): For 9MFY24, it was Rs 1,432 crore, a decrease from Rs 1,886 crore in 9MFY23.
  • Profit After Tax (PAT): For 9MFY24, it reached Rs 1,045 crore, down from Rs 1,489 crore in 9MFY23.
  • Forex Gain: For 9MFY24, it stood at Rs 29 crore, a decline from Rs 137 crore in 9MFY23.

Result PDF

View Other Company Results

Divis Laboratories Ltd shares SWOT Analysis

Strengths (9)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Strong QoQ EPS Growth in recent results
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (4)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
Discover More

Resistance and support

R1 4,595.9
R2 4,621.1
R3 4,643.2
Pivot

4,573.82

S1 4,548.7
S2 4,526.6
S3 4,501.4
EMA SMA
4,536.7
4,363.5
4,146.6
3,937.0
4,552.8
4,348.2
3,998.3
3,844.0
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
NORTHERN LIGHTS FUND TRUST III RONDURE NEW WORLD FUND Block Purchase 2023-10-20 3637.7 43478 BSE
RONDURE NEW WORLD FUND Block Sell 2023-10-20 3637.7 43478 BSE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-11-14 3271.4 209124 NSE
Discover More
Name Category Shares
NILIMA PRASAD DIVI PROMOTER 20.34%
SATCHANDRA KIRAN DIVI PROMOTER 20.34%
SWARNA LATHA DIVI PROMOTER 5.27%
MURALI KRISHNA PRASAD DIVI PROMOTER 2.85%
DIVI'S BIOTECH PRIVATE LIMITED PROMOTER 3.01%

OUR RESEARCH VIEW

Investment recommendation
Strong recovery in Custom Synthesis...
Call Date
27 May 2024
Entry Price 4,100.00
Target Price 4,030.00
Duration
12-18 Month
HOLD View Report
DISCOVER MORE

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Divis Laboratories Ltd Stocks COMPARISON

Financials( ₹ in Cr) Divis Laboratories Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Zydus Lifesciences Ltd Dr Reddys Laboratories Ltd
Price 4,570.80 1,579.30 1,510.40 1,184.80 6,646.05
% Change -1.43 -1.20 -0.19 0.39 0.81
Mcap ₹ Cr 121,340.57 378,926.98 121,944.71 119,218.60 110,868.08
Revenue TTM ₹ Cr 7,665.00 48,496.85 15,790.60 19,547.40 28,011.10
Net Profit TTM ₹ Cr 1,576.00 9,648.44 2,513.47 3,854.40 5,577.90
PE TTM 75.74 37.93 28.66 30.89 20.11
1 Year Return 25.57 51.13 48.56 103.71 28.93
ROCE 16.27 17.20 14.76 23.94 26.59
ROE 12.04 16.13 10.66 20.64 21.64
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 13,484.00 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42
Divi`s Laboratories Limited - Record Date

Jul 16, 2024 l NSE Announcement

Divi`s Laboratories Limited - Shareholders meeting

Jul 15, 2024 l NSE Announcement

DISCOVER MORE
Date Action Type Ratio
Aug 02, 2024 Dividend 1500
Aug 11, 2023 Dividend 1500
Aug 11, 2022 Dividend 1500
DISCOVER MORE

Divis Laboratories Ltd Information

Stock PE (TTM)
75.74
Promoter Holding
51.92%
Book Value
511.2128
ROCE
16.27%
ROE
12.04%
Registered Address

1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli, Hyderabad, Telangana, 500032

Tel : 91-40-23786300/23786352/400
Email : mail:divislaboratories.com; cs:divislaboratories.c
Website : http://www.divislabs.com
Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 532488
NSE Code : DIVISLAB
Book Closure Date (Month) :
BSE Group : A
ISIN : INE361B01024

FAQ’s on Divis Laboratories Ltd Shares

You can buy Divis Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Divis Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 03:55 PM the closing price of Divis Laboratories Ltd was Rs.4,570.80.

The latest PE ratio of Divis Laboratories Ltd as of Jul 16, 2024 03:55 PM is 75.74

The latest PB ratio of Divis Laboratories Ltd as of Jul 16, 2024 03:55 PM is 0.11

The 52-week high of Divis Laboratories Ltd share price is Rs. 4,670.00 while the 52-week low is Rs. 3,295.30

According to analyst recommendations, Divis Laboratories Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 03:55 PM, the market cap of Divis Laboratories Ltd stood at Rs. 121,340.57 Cr.

Download App

Download Our App

Play Store App Store
market app